Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.835 USD | -1.87% | -3.89% | -87.40% |
May. 14 | Mizuho Cuts Price Target on Amylyx Pharmaceuticals to $3 From $4, Keeps Neutral Rating | MT |
May. 09 | Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.40% | 127M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-9.10% | 33.03B | |
+55.32% | 24.68B | |
-16.55% | 15.12B | |
-9.16% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Top Premarket Decliners